Relationship between IgG titers and opsonocytophagocytic activity of anti-pneumococcal antibodies after immunization with the 7-valent conjugate vaccine in allogeneic stem cell transplant
Authors:
- C CordonnierCCC Cordonnier
- M LabopinMLM Labopin
- K U JansenKJK U Jansen
- M PrideMPM Pride
- E BonnetEBE Bonnet
- H EinseleHEH Einsele
- P LjungmanPLP Ljungman
- for the Infectious Diseases Working Party (IDWP) of the European Group for Blood and Marrow Transplantation Group (EBMT)F(for the Infectious Diseases Working Party (IDWP) of the European Group for Blood and Marrow Transplantation Group (EBMT)
- 21 December 2009
- journal article
- research article
- Published by Springer Nature in Bone Marrow Transplantation
- Vol. 45 (9) , 1423-1426
Abstract
The European Group for Blood and Marrow Transplantation has recently run a prospective, randomized trial comparing an early (3 months) vs a late (9 months) immunization program after allo-SCT with three doses of the conjugate 7-valent pneumococcal vaccine. This trial has shown that the response rate assessed 1 month after the third dose of conjugate vaccine was not inferior after an early vaccination vs a late vaccination. Part of the responder cohort of these patients (n=28) were chosen to assess the functionality of the anti-pneumococcal antibodies through an opsonophagocytic assay, 1 month after the third dose of conjugate vaccine. We have assessed the relationship between IgG titers measured by the pneumococcal ELISA and functional titers measured by opsonophagocytic assay of anti-pneumococcal antibodies. We found a significant correlation between titers for both assays, and conclude that the response to PCV7 after SCT induces functional antibodies.Keywords
This publication has 13 references indexed in Scilit:
- Randomized Study of Early versus Late Immunization with Pneumococcal Conjugate Vaccine after Allogeneic Stem Cell TransplantationClinical Infectious Diseases, 2009
- A Randomized, Double-Blind Trial of Pneumococcal Vaccination in Adult Allogeneic Stem Cell Transplant Donors and RecipientsClinical Infectious Diseases, 2007
- Estimating the protective concentration of anti-pneumococcal capsular polysaccharide antibodiesVaccine, 2007
- Pneumococcal conjugate vaccine provides early protective antibody responses in children after related and unrelated allogeneic hematopoietic stem cell transplantationBlood, 2006
- Approach to Validating an Opsonophagocytic Assay for Streptococcus pneumoniaeClinical and Vaccine Immunology, 2005
- Donor immunization with pneumococcal conjugate vaccine and early protective antibody responses following allogeneic hematopoietic cell transplantationBlood, 2003
- Early and late invasive pneumococcal infection following stem cell transplantation: a European Bone Marrow Transplantation surveyBritish Journal of Haematology, 2002
- Pneumococcal Type 22F Polysaccharide Absorption Improves the Specificity of a Pneumococcal-Polysaccharide Enzyme-Linked Immunosorbent AssayClinical and Diagnostic Laboratory Immunology, 2001
- Safety and immunogenicity of heptavalent pneumococcal CRM197 conjugate vaccine in infants and toddlersThe Pediatric Infectious Disease Journal, 1999
- Pneumococcal immunity and response to immunization with pneumococcal vaccine in bone marrow transplant patients: the influence of graft versus host reactionSupportive Care in Cancer, 1993